Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
25 hedge funds and large institutions have $5.78M invested in Fibrocell Science Inc. in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
0% more funds holding
Funds holding: 25 → 25 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less capital invested
Capital invested by funds: $6.49M → $5.78M (-$710K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$444K |
| 2 |
VF
Virtu Financial
New York
|
+$52.8K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$25.2K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$23.5K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$18.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$317K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$216K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$20.5K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$399 |
| 5 |
MP
MSD Partners
New York
|
-$345 |
FCSC Hedge Fund Activity: Q3 2018 in Review
25 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2018, worth a combined $5.78M — down 11% from $6.49M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FCSC positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $444K. The largest seller was CVI Holdings, exiting entirely with an estimated $317K sold.
- 25 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $5.78M of Fibrocell Science Inc. stock for Q3 2018, down 11% quarter-over-quarter.
- 4 funds opened new Fibrocell Science Inc. positions in Q3 2018 and 3 closed out, a net change of +1 holder.
- The largest Fibrocell Science Inc. buyer in Q3 2018 was Renaissance Technologies, an estimated $444K added.
- The largest Fibrocell Science Inc. seller in Q3 2018 was CVI Holdings, an estimated $317K sold.
Based on aggregated 13F filings for Q3 2018.